In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound.
Read more...
Hence then, the article about eli lilly is stepping up its fight against copycat weight loss drugs was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Lilly is stepping up its fight against copycat weight-loss drugs )
Also on site :
- STL assure une connectivité ultra-rapide avec Mynet pour un centre de données au « cœur des montagnes »
- genOway:Revolucionando la predicción de terapias con anticuerpos en humanos con un modelo de ratón único
- Building an Intelligent Network for Terminal-Network-Service Collaboration and Business Success